These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline]. Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C advances in antiviral therapy: what is accepted treatment now? McHutchison JG J Gastroenterol Hepatol; 2002 Apr; 17(4):431-41. PubMed ID: 11982724 [TBL] [Abstract][Full Text] [Related]
7. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment. Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL; Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795 [TBL] [Abstract][Full Text] [Related]
8. Consensus guidelines for the management of hepatitis C infection. Consensus Guidelines Committee for the Management of Hepatitis C Infection Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186 [TBL] [Abstract][Full Text] [Related]
9. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225 [TBL] [Abstract][Full Text] [Related]
10. [Importance of adherence for efficacy of hepatitis C combined therapy]. Nožić D; Delić D; Božić M; Fabri M; Svorcan P; Konstantinović L Srp Arh Celok Lek; 2013; 141(7-8):507-10. PubMed ID: 24073558 [TBL] [Abstract][Full Text] [Related]
11. Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study. Lang JP; Melin P; Ouzan D; Rotily M; Fontanges T; Marcellin P; Chousterman M; Cacoub P; Antivir Ther; 2010; 15(4):599-606. PubMed ID: 20587853 [TBL] [Abstract][Full Text] [Related]
12. Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice. Niederau C; Mauss S; Böker K; Lutz T; Heyne R; Moog G; John C; Witthöft T; Alshuth U; Hüppe D Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):65-73. PubMed ID: 23751351 [TBL] [Abstract][Full Text] [Related]
13. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists. Deming P; McNicholl IR Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625 [TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250 [TBL] [Abstract][Full Text] [Related]
15. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)]. Pár A; Tornai I; Szalay F Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063 [TBL] [Abstract][Full Text] [Related]
17. Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child? Serranti D; Buonsenso D; Ceccarelli M; Gargiullo L; Ranno O; Valentini P Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1057-67. PubMed ID: 22013729 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. Shepherd J; Waugh N; Hewitson P Health Technol Assess; 2000; 4(33):1-67. PubMed ID: 11134916 [TBL] [Abstract][Full Text] [Related]
19. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
20. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule]. Horváth G; Tolvaj G; Halász T; Stotz G Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]